Stockreport

Keros Therapeutics Appoints Jean-Jacques Bienaimé to its Board of Directors [Yahoo! Finance]

Keros Therapeutics, Inc. - common stock  (KROS) 
PDF company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the t [Read more]